Pieris Pharmaceuticals (PIRS) has the following price history information. Looking back at PIRS historical stock prices for the last five trading days, on April 12, 2024, PIRS opened at $0.17, traded as high as $0.18 and as low as $0.17, and closed at $0.17. Trading volume was a total of 233.20K shares. On April 15, 2024, PIRS opened at $0.17, traded as high as $0.17 and as low as $0.16, and closed at $0.17. Trading volume was a total of 562.10K shares. On April 16, 2024, PIRS opened at $0.17, traded as high as $0.17 and as low as $0.16, and closed at $0.16. Trading volume was a total of 320.60K shares. On April 17, 2024, PIRS opened at $0.17, traded as high as $0.17 and as low as $0.15, and closed at $0.16. Trading volume was a total of 625.40K shares. On April 18, 2024, PIRS opened at $0.16, traded as high as $0.17 and as low as $0.15, and closed at $0.15. Trading volume was a total of 635.80K shares.

PIRS Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Pieris Pharmaceuticals shares, starting with a $10,000 purchase of PIRS, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	04/14/2015
End date:	04/18/2024
Start price/share:	$3.50
End price/share:	$0.15
Dividends collected/share:	$0.00
Total return:	-95.57%
Average Annual Total Return:	-29.22%
Starting investment:	$10,000.00
Ending investment:	$442.91
Years:	9.02

PIRS Historical Price Range
Date	Open	High	Low	Close	Volume
04/12/2024	$0.17	$0.18	$0.17	$0.17	233.20K
04/15/2024	$0.17	$0.17	$0.16	$0.17	562.10K
04/16/2024	$0.17	$0.17	$0.16	$0.16	320.60K
04/17/2024	$0.17	$0.17	$0.15	$0.16	625.40K
04/18/2024	$0.16	$0.17	$0.15	$0.15	635.80K

About Pieris Pharmaceuticals

Pieris Pharmaceuticals is a biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. Co.'s clinical pipeline includes elarekibep an inhaled IL-4Ra antagonist Anticalin protein to treat uncontrolled asthma, PRS-220, an inhaled CTGF antagonist to treat IPF and other forms for fibrotic lung disease, an immuno-oncology (IO) bispecific PRS-344/S095012 targeting PD-L1 and 4-1BB. Co. has intellectual property rights directed to various aspects of its Anticalin technology platform, allowing for the development and improvement of both its platform and drug candidates. Co.'s development plans focus on its clinical and preclinical programs.

PIRS Historical Closing Prices
Date	Close
04/12/2024	$0.17
04/15/2024	$0.17
04/16/2024	$0.16
04/17/2024	$0.16
04/18/2024	$0.15

Healthcare Historical Prices

PIRS is categorized under the Healthcare sector; below are some other companies in the same sector: PKI Historical Stock Prices PLB Historical Stock Prices PLI Historical Stock Prices PLSE Historical Stock Prices PLX Historical Stock Prices PLXP Historical Stock Prices PMC Historical Stock Prices PMD Historical Stock Prices PODD Historical Stock Prices POZN Historical Stock Prices Also explore: PIRS shares outstanding history Free PIRS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts

PIRS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.